Chemoprevention of Colon Carcinogenesis by the Synthetic Organoselenium Compound 1,4-Pheny lenebis(methy lene)selenocyanate

Cancer Research

Volumn 52, Issue 20, 1992, Pages 5635-5640

  Upadhyaya, Pramod ^b   El Bayoumy, Karam ^b  

^a Divisions of Nutritional Carcinogenesis ^*  (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; ORGANOSELENIUM DERIVATIVE; PROSTAGLANDIN E2; SELENIUM;

ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED CANCER; DRUG MECHANISM; ENZYME ACTIVITY; MALE; MAXIMUM PERMISSIBLE DOSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ADENOCARCINOMA; ANIMAL; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; COLONIC NEOPLASMS; DIETARY FATS; EATING; INTESTINAL MUCOSA; MALE; ORGANOSELENIUM COMPOUNDS; RATS; RATS, INBRED F344; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026699250     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Schrauzer, G. N., White, D. A., and Schneider, C. J. Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes. Bioinorg. Chem., 7: 23-34, 1977.
2. Shamberger, R. J., and Wills, C. E. Selenium distribution and human cancer mortality. CRC Crit. Rev. Clin. Lab. Sci., 2: 211-221, 1971.
3. Clark, L. C. The epidemiology of selenium and cancer. Fed. Proc., 44:2584-2589, 1985.
4. Willet, W. C., and Stampfer, M. J. Selenium and human cancer: epidemiological aspects and implications for clinical trials. J. Am. Coll. Toxicol., 5: 29-36, 1986.
5. Willet, W. C., and Stampfer, M. J. Selenium and cancer: whether selenium protects against cancer is still unknown. Br. Med. J., 297: 573-574, 1988.
6. Clayton, C. C., and Bauman, C. A. Diet and azo dye tumors: effect of diet during a period when the dye is not fed. Cancer Res., 9: 575-582, 1949.
7. Griffin, A. C., and Jacobs, M. M. Effects of selenium on azo dye hepatocarcinogenesis. Cancer Lett., 3: 177-181, 1977.
8. Thompson, H. J., Meeker, L. D., and Kokosa, S. Effect of an inorganic and organic forms of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res., 44: 2803-2806, 1984.
9. Ip, C. Selenium inhibition of chemical carcinogenesis. Fed. Proc., 44:2573-2578, 1985.
10. Medina, D. Selenium and murine mammary tumorigenesis. In: B. S. Reddy and L. A. Cohen (eds.), Diet, Nutrition, and Cancer: A Critical Evaluation, Vol. 2, pp. 23-41. Boca Raton, FL: CRC Press, 1986.
11. Jacobs, M. M., Frost, C. F., and Beams, F. A. Biochemical and clinical effects of selenium on dimethylhydrazine-induced colon cancer in rats. Cancer Res., 44: 4458-4465, 1981.
12. Birt, D. F., Julius, A. D., Runice, C. E., and Salmasi, S. Effects of dietary selenium on bis-(2-oxopropyl)-nitrosamine-induced carcinogenesis in Syrian golden hamsters. J. Natl. Cancer Inst., 77: 1281-1286, 1986.
13. Buell, D. N. Potential hazards of selenium as a chemopreventive agent. Semin. Oncol., 10: 311-321, 1983.
14. Ip, G., and White, G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis (Lond.), 8: 1763-1766, 1987.
15. Thompson, H. J., Meeker, L. D., and Kokosa, A. S. Effect of inorganic and organic forms of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res., 44: 2803-2806, 1984.
16. Milner, J. A., and Hsu, J. A. Inhibitory effects of selenium on the growth of L1210 leukemic cells. Cancer Res., 41: 1652-1656, 1983.
17. El-Bayoumy, K. The role of selenium in cancer prevention. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer Prevention, pp. 1-15. Philadelphia: J. B. Lippincott Co., 1991.
18. Nayini, J. R., Sugie, S., El-Bayoumy, K., Rao, C. V., Rigotty, J., Sohn, O-S., and Reddy, B. S. Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr. Cancer, 15: 129-139, 1991.
19. El-Bayoumy, K., Upadhyaya, P., Date, V., Sohn, O-S., Fiala, E. S., and Reddy, B. S. Metabolism of [14C]benzylselenocyanate in F344 rats. Chem. Res. Toxicol., 4: 560-564, 1991.
20. Conaway, C. C., Upadhyaya, P., Meschter, C., Marcus, L. A., and El-Bayoumy, K. Subchronic toxicity of benzylselenocyanate and 1,4-phenylenebis-(methylene)-selenocyanate in F344 rats. Fundam. Appl. Toxicol., in press, 1992.
21. Rotruck, J. T., Pope, A. L., Ganther, H. E., and Hoekstra, W. G. Selenium: biochemical role as a component of glutathione peroxidase. Science (Washington DC), 179: 588-590, 1973.
22. Oh, S. H., Ganther, H. E., and Hoekstra, W. G. Selenium as a component of gluthatione peroxidase isolated from bovine erythrocytes. Biochemistry, 13: 1823-1829, 1974.
23. Reddy, B. S., Tanaka, T., and El-Bayoumy, K. Inhibitory effect of dietary Mnethoxybenzeleselenol on azoxymethane-induced colon and kidney carcinogenesis in female F344 rats. J. Natl. Cancer Inst., 74: 1325-1328, 1985.
24. Honn, K. V., Bockman, R. S., and Mamett, L. J. Prostaglandins and cancer. A review of tumor initiation through tumor metastasis. Prostaglandins, 21: 833-864, 1981.
25. Furuta, Y., Hall, E. R., Sanduja, S., Barkley, T., Jr., and Milas, L. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res., 48: 3002-3007, 1988.
26. Reddy, C. C., Li, N. G., Reddy, P. S., Hildenbrandt, G. R., Reddy, A. P., Scholz, R. W., and Tu, C. P. D. Selenium-dependent glutathione peroxidase: expression in selenium deficiency. In: C. C. Reddy, G. A. Hamilton, and K. M. Madyastha (eds.), Biological Oxidation Systems, Vol. 1, pp. 473-485. New York: Academic Press, 1991.
27. Rao, C. V., and Reddy, B. S. Effect of amount and types of dietary fat on modulation of carcinogen-induced early events in rat colon. Proc. Am. Assoc. Cancer Res., 33: 953, 1992.
28. Reddy, B. S., and Maruyama, H. Effect of different levels of dietary corn oil and lard during the initiation phase of colon carcinogenesis in F344 rats. J. Natl. Cancer Inst., 77: 815-822, 1986.
29. Pozharisski, K. M. Morphology and morphogenesis of experimental epithelial tumors of the intestine. J. Natl. Cancer Inst., 54: 1115-1135, 1975.
30. Elwell, M. R., and McConnell, E. E. Small and large intestine. In: G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr., and W. F. Mackenzie (eds.), Pathology of the Fischer Rat, pp. 43-61. New York: Academic Press, Inc., 1990.
31. Maclouf, J., Pradel, M., Pradelles, P., and Dray, F. I25I derivatives of prostaglandins. A novel approach in prostaglandin analysis by radioimmunoassay. Biochim. Biophys. Acta, 431: 139-146, 1976.
32. Pagila, D. E., and Valentine, W. N. Studies on the qualitative and quantitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70: 158-169, 1967.
33. Laurance, R. A., and Burk, R. F. Glutathione peroxidase activity in selenium-deficient liver. Biochem. Biophys. Res. Commun., 71: 962-968, 1976.
34. Caromagnol, F., Sinet, P. M., and Jerome, H. Selenium-dependent and nonselenium-dependent glutathione peroxidase in human tissue extracts. Biochim. Biophys. Acta, 759:49-57, 1983.
35. El-Bayoumy, K., Chae, Y-H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
36. Ip, C., Wilson, A. G., Singh, M., Thompson, H., Upadhyaya, P., and El-Bayoumy, K. Evaluation of the chemopreventive efficacy of 1,4-phenylenebis-(methylene)selenocyanate (XSC) by in vitro and in vivo models. Proc. Am. Assoc. Cancer Res., 33: 970, 1992.
37. Wattengerg, L. W. Inhibitors of chemical carcinogens. Adv. Cancer Res., 26: 197-226, 1975.
38. Fiala, E. S. Investigations into the metabolism and mode of the colon carcinogens, 1,2-dimethylhydrazine and azoxymethane. Cancer (Phila.), 40: 2436-2445, 1977.
39. Fiala, E. S., Kulakis, C., Christiansen, G., and Weisburger, J. H. Inhibition of metabolism of colon carcinogen, azoxymethane, by pyrazole. Cancer Res., 38:4515-4521, 1978.
40. Fiala, E. S., Joseph, C., Sohn, O-S., El-Bayoumy, K., and Reddy, B. S. Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res., 51: 2826-2830, 1991.
41. Fulton, A. M. Interactions of natural effector cells and prostaglandins in the control of metastasis. J. Natl. Cancer Inst., 78: 735-741, 1987.
42. Karmali, R. A. Prostaglandins and cancer. CA Cancer J. Clin., 33:322-332, 1983.
43. Bennett, A., and Del Tacca, M. Prostaglandins in human colonic carcinoma. Gut, 16:409, 1975.
44. Young, M. R., and Knies, S. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo. J. Natl. Cancer Inst., 72:919-922, 1984.
45. Mahan, M., Meunier, J., Newby, M., and Young, M. R. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination. J. Natl. Cancer Inst., 74: 191-195, 1985.
46. Reddy, B. S., Nayini, J., Tokumo, K., Rigotty, J., Zang E., and Kelloff, G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug, with D.,L-α-difluoromethy-lornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res., 50: 2562-2568, 1990.
47. Sohn, O-S., Blackwell, L., Mathis, J., Assad, W. W., Reddy, B. S., and El-Bayoumy, K. Excretion and tissue distribution of selenium following treatment of male F344 rats with benzylselenocyanate or sodium selenite. Drug Metab. Dispos., 19: 865-870, 1991.